ArticleCell death & disease2025

Targeting intrinsically disordered nuclear protein 1 (NUPR1) with single-domain antibodies alleviates triple-negative breast cancer (TNBC) progression in vivo.

Tianzhuo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.